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THESIS ABSTRACT
Linda Jeanne Hall
DfL-Threo-N^-acetyl-3-fluoroasparaffine methyl ester
(AcFAsni’Ie) was synthesised by Duschinsky at the Swiss
Institute fcr Experimental Research who found that it in¬
hibited L5178Y and LI210 mouse leukemic cell lines.
It
was initially thought that this compound might be de¬
blocked by acylases and esterases in vivo to yield 3-fluorcasparagine which could act as an asparagine analog to inhibit
cell growth.
As such it might have a role in the chemother¬
apy of leukemia, either alone or in conjunction with L-asparaginase.
Therefore, in this thesis, attempts were made to
remove the blocking groups from AcEAsnAe with several ester¬
ases and an acylase.
Unfortunately, these enzymes proved
ineffective•
To expand the cytotoxicity studies in cell culture
systems, a technique was devised to permit assay of drum
effects on L5175Y leukemic cell growth in 24-well plastic
trays.
The cytotoxicity of AcEAsnAe was studied in this
system and 50% inhibition of growth was observed at concen¬
trations of 6 x 10 ”7 A.
Addition of up to 20-fold the normal
medium concentration of L-asparagine did not significantiy
protect against the cytotoxic effects of AcEAsniue*
Therefore, studies with AcEAsnme were continued from
a somewhat different perspective.
Duschinsky had shown that
an aqueous solution of AcEAsrjAe in phosphate buffer pH 7 at
room temperature developed a UV maximum at 273 nm within 70
hours.
In 0.1 N NaOH this transition to 233 nn absorbing
material occurred immediately and was followed by emergence
with 15-20 minutes of a maximum at 267 nm.
In cur studies
with L5178Y it was shown that prs-incubaticr. of AcEAsnAe
with media for 20 hours crier to addition of ceils did net
reduce the growth inhibitory effect.
This result suggested
that one of the degradation products might be responsible for
inhibition since at pH 7 AcEAsnMe undergoes complete conver¬
sion at 37° to the 233 nm absorbing material within 280 min¬
utes.
An investigation of the chemical nature of the 233 nm
absorbing product as well as the other possible degradation
products was undertaken.
It was shown that at pH 8.3 one
mole of acid was liberated for every mole of AcEAsniue present
with a Tip of 20 minutes.
When the concentration of AcEAsmVIe
was C.25 M, conversion to the 233 nm absorbing product by
titrimetric addition of 1 N NaCH at pH 8.8 was associated wit
formation of a crystalline precipitate which was subseauertly
filt ered and recrystallized from HoC.
M.iR studies revealed
that during conversion of AcEAsnMe to the 2 33 nm absorbing
product, HE had been liberated as well as MeCH.
The proposed

*
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structure for the 233 nm absorbing compound was 2-(N-acet yUaminomaleimide (NAAM)•
Further characterization of this ccmpound showed it tc be a white crystalline solid which wit
slow heating, decomposed at >260° and with rapid heating
showed evidence of sublimation.
From mass spectroscopy s tua ies a molecular weight of 154 was determined, and element ai
analysis yielded 46.91% C, 3*33% H, 18.21% N (theoretical
46.75% C* 3*93% H, 13.18% N).
UV spectroscopy and TLC we re
used to further characterize the degradation products whi ch
had formed in addition to NAAM.
From these studies, a me chanism for the reaction of AcFAsnMe at pH 8.3 or in culture
medium was proposed.
Crystalline NAAM caused approximately 55% inhibition of
the growth of L51?8Y cells at a concentration of 4 x 10M.
Since the other degradation products were not found to be
cytotoxic in the same system, it was concluded that NAAM was
indeed the compound responsible for inhibition.
Presumably,
this previously unreported compound acts as an alkylating
agent, as numerous other maleimide derivatives have been
shown to function.
Initial studies with NAAM have shown that
it does react with L-cysteine, a strong nucleophile.
Further
studies are needed to determine the applicability of NAAM in
the field of cancer chemotherapy.

.

ACKNOWLEDGEMENTS
I wish to express my sincere appreciation to my
advisor. Dr. Robert Handschumacher, for investing great
quantities of time, for his keen insight, and for his
continued guidance, support and friendship; to Dr. R.
Duschinsky for providing the starting material and there¬
fore the opportunity for this research; to 3arbara Stanley
for her aid in tissue culture techniques; to Dr. Ian
Armitage, Dr. JoAnne Stubbe, Dr. Pauline Chang, and Dr. Ann
Jacubowski for their help with the chemical aspects of this
thesis; and to Connie Lehman, Dr. Fauline Schwartz and James
Moyer for their generous assistance, support and friendship
throughout the course of this research.

To My Parents

TABLE OF CONTENTS

PAGE
INTRODUCTION

1

MATERIALS AND METHODS

7

RESULTS

15

DISCUSSION

44

REFERENCES

57

INTRODUCTION

2

INTRODUCTION

The enzyme L-asparaginase

is an effective chemothera¬

peutic agent in the treatment of certain human leukemias
(1,2).

By converting L-asparagine to L-aspartic acid,

it

causes death of those tumor cells which require L-asparagine
for growth (3**0 •

Unfortunately,

treatment with L-asparagin¬

ase is associated with a wide range of toxic effects

(5)»

and the duration of remission in patients responding to the
drue is brief

(6).

For this reason a search for asparagine

analogs which migrht replace or supplement L-aspara^inase

in

the treatment of asparagine-requiring tumors was begun.

Cne

such analog,

5~diazo-4-oxo-L-norvaline was shown to inhibit

the growth of L5178Y asparagine-dependent leukemic cells

(7).

Other analogs include the 5-bromo and 5-chloro derivatives
of L-2-amino-4-oxopentanoic acid, which at 3 x 10“-5 ivi were
shown to inhibit L517SY cell growth by 48 and
respectively

(8).

90 per cent,

L-2-Amino-4-oxopentanoic acid

caused 37 per cent inhibition of L5178Y cells

itself

(8).

In addi¬

tion to the ability of these asparagine analogs to inhibit
the growth of asparagine-dependent cell lines by inhibiting
asparagine synthesis,

these compounds have provided a means

of studying the active site of L-asparaginase,
in the development of new asparagine analogs.

thereby aiding

*
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Another approach to the chemotherapy of leukemia
involves a search for inhibitors of L-asparagine synthe¬
tase.

This is based on the finding; that development of

asparaginase-resistant variants from asparaginase-sensi¬
tive lines was consistently associated with acquisition
of asparagine synthetase activity in both mouse and human
leukemias

(9#10).

Apparently,

the resistant cells have

derepressed the formation of asparagine synthetase
Therefore,

(11).

if inhibition or prevention of the derepression

of this enzyme could

be accomplished,

the tumor cells

should retain their sensitivity to L-asparaginase•
this regard,

In

one study examined the ability of asparagine

analogs to inhibit the growth of L5178Y sublines which
contain an asparagrine-independent form of asparagine syn¬
thetase and found the most effective analogs to be L-/3-aspartyl methylamide, L-^-aspartyl hydroxamate,
partyl hydrazide

(11,

12).

and L-/3-as-

When L-/-aspartyl methylamide

was administered to mice bearing various asparaginase-resis¬
tant tumors,

life span was increased from

Unfortunately,

31 to 79 per cent.

there has been little success using the

known inhibitors to re-establish sensitivity in cases which
have developed clinical resistance.
reasons include

(13)»

Possible contributory

(a) dietary L-asparagine may be car¬

ried to the tumor cell in compartments which are impermeable
to L-asparaginasej

(b) L-asparagine may be synthesized by

alternative routes not susceptible to the known inhibitors;
(c) many different L-asparagine synthetases may exist with

4
different susceptibility to inhibition; and (d) more power¬
ful inhibitors of L-asparagine synthetase may be required to
completely inhibit the synthesis of L-asparagine.

In this

regard, a systematic examination was made of a wide variety
of compounds as inhibitors of L-asparagine synthetase of
L-asparaginase resistant L5178Y leukemia (13)*

The nitroso¬

ureas BCNU, CCNU, and methyl-CCNU, as well as showdomycin,
for example, were found to inhibit L-asparagine synthetase
at ImM concentrations in addition to possessing antitumor
activity.

Unfortunately, the correlation of enzyme inhibi¬

tory potency with oncolytic potency could not be established.
Thus, the search for asparagine analogs which may expand
the spectrum of L-asparaginase therapy continues.

A fluorin-

ated analog of L-asparagine would seem to be a logical candi¬
date based on the high reactivity and. known toxicity of com¬
pounds such as 5-fluorouracil (14).

^-/-Difluoroasparagine

has just recently been synthesized, but was found to be in¬
active in non-toxic doses when tested in vivo in CDF-1 mice
with asparagine-dependent L5178Y leukemia (15)•

Although

several mono-fluorinated amino acids such as ^-fluoroalanir.e
(16), <*-fluoro-/-alanine (17)* and 5-fluoronorvaline (18)
have been prepared, synthesis of p-1luoroasparagine has
never been reported.

This is most likely due to the rela¬

tive instability of certain fluorinated amino acids due to
loss of the fluorine atom by ^-elimination as hydrofluoric
acid

(19)*

In this regard, the attempted synthesis of

/$-fluoroaspartic acid by routine methods was unsuccessful (20).

5
This thesis presents an investigation of the recently
synthesized mono-fluorinated asparagine analog, D,L-threoN^-acetyl-3-fluoroasparagine methyl ester (AcFAsnMe)

(21),

which has been kindly supplied by Dr. Robert Duschinsky at
the Swiss Institute for Experimental Research.

It was

hoped that in vivo this compound might undergo deacylation
and demethylation thus yielding 3“fluoroasparagine•

Pre¬

liminary studies of AcFAsnMe by Duschinsky indicated that
it caused dose-dependent growth inhibition of L5178Y and
L1210 mouse leukemia cells in cell culture (22).

In addi¬

tion, L-asparagine appeared to provide some protection
against the cytotoxicity, suggesting that the drug was act¬
ing as an asparagine analog.

The drug is stable in aqueous

solution at pH 4 to 6 but at pH 7*6,

it decomposes completely

in less than 5 hours as measured by the appearance of an
ultraviolet absorption maximum at 233 nm.

Therefore, the

question was raised as to whether AcFAsnMe itself or the
degradation product was responsible for inhibition of cell
growth.
Thus, in this thesis, the cytotoxicity of AcFAsnMe
against L5178Y mouse leukemia cells with and without L-asparagine was further investigated.

The susceptibility of this

blocked analog of L-asparagine to esterases and acylases
was also studied to determine if 3“f'luoroasparagine was
liberated from the parent compound.

Finally, the biologically

active degradation product formed from AcFAsnMe was chem¬
ically characterized to be 2-(N-acetyl)-aminomaleimide (NAAM).

6

A mechanism for the mode of its formation from AcFAsnMe is
presented along with proposals concerning the nature of the
inactive degradation products.

MATERIALS AND METHODS
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MATERIALS AND METHODS
I,
Cell Culture Studies with D,L-Threo-N^-acetvl-3-fluoroasparagine Methyl Ester (AcFAsnMe).
All lymphoblasts used in these experiments were obtain¬
ed from stock cultures of L5178Y mouse leukemia cell lines
which were maintained between 1 x 10^ and 1 x 10-* cells/ml
by serial passage in Fischer's medium with 10% horse serum
(23)# both from Grand Island Biological Company.

An 8.0 mM

solution of L-asparagine (Calbiochem) was prepared in Fisch¬
er's medium, sterile filtered and supplemented to contain
10% horse serum.

This concentration included the 0.4 mM

L-asparagine present in Fischer's medium.

A 5*2 mM solution

of L-glutamine (Nutritional Biochemical Corporation) was pre¬
pared in a similar manner and added to some cell cultures.
This concentration included the 1.4 mM L-glutamine already
present in Fischer's medium.
AcFAsnMe v/as kindly supplied by Dr. R. Duschinsky of
the Swiss Institute for Experimental Research, Lausanne.
Stock solutions (2.4 x 10“^ M) were prepared in distilled
water and sterile filtered.

The pH of such solutions v/as

approximately 5 and assured stability prior to addition to
the cultures.

Subsequent dilutions as required were made

with sterile water.

All additions of drug were in less than

10% of the culture medium.
Preliminary studies of AcFAsnMe by Duschinsky (22)
indicated that it is stable at its acidic pH, showing only

9
end absorption in the ultraviolet spectrophotometer.

How¬

ever, in phosphate buffer pH 7» 25°, the solution develops
a UV maximum at 233 nm (£ - 8400, based on the original con¬
centration of AcFAsnMe) within 70 hours (half-life = approxi¬
mately 19 hours).

At 37°, a 10”^ M solution of the compound

in 10“2 M phosphate buffer pH 7*65 decayed completely within
280 minutes, measured by formation of the maximum at 233 run.
In 0.1 N NaOH, at 25°, formation of an immediate temporary
maximum that occurred at 230-235 nm was followed by emergence
of a maximum at 267 nm (£ = 8800, based on the original con¬
centration of AcFAsnMe) within 15 to 20 minutes.
Cultures of L5178Y cells were grown in Linbro 24-well
plates with 1.0 ml final volume per well.

Compounds were

added in 0.1 ml to 0.8 ml Fischer*s medium containing 10%
serum with or without added L-asparagine.

Cne tenth ml of

L5178Y cell suspension was added to start the cultures at
approximately 10^ cells/ml.

The cultures were incubated at

37° in a 5% CC2~in-air humidified incubator.
In some experiments AcFAsnMe was pre-incubated in
media with or without L-asparagine for 20 hours prior to
addition of cells.

Growth in these solutions was compared

with freshly prepared solutions of AcFAsnMe in media with
or without L-asparagine.
Cell culture plates were examined under light microscopy for signs of contamination and/or cell damage at 24,
48, and 72 hours.

To assess the rate of growth, the con¬

tents of each well were removed by Pasteur pipet into 9 nil
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of 0*9% NaCl and cell counts were determined by use of the
Coulter Counter.

All cell growth data points are the aver¬

age of triplicate determinations.

The doubling rates for

L5178Y controls using this culture technique compared favor¬
ably with those found using standard cell culture tubes con¬
taining 5 nil of media (see Discussion).
II.

Enzymatic Treatment of AcFAsnMe.
Pseudocholinesterase or acylcholine acyl-hydrolase

(Sigma)

(1 unit hydrolyzes 1.0 pmole of butyrylcholine per

minute at pH 8.0, 37°) was dissolved in 0.01 M KH2PO4 buffer
pH 7*5* and 3*6 to 7*8 units were added to various substrates
to start the reaction.

Esterase type I from hog liver

(Sigma), a suspension in 3*2 M (NH^^SG^ solution (1 unit
hydrolyzes 1.0 pinole of ethyl butyrate per minute, pH 8.0,
25°) was diluted in buffer and between 5*0 and 6.5 units
were added to the various substrates to start the reaction.
Esterase type II or carboxylic ester hydrolase from hog
liver (Sigma), a suspension in 3*2 M (NH/i^SCzj. solution,
pH 6.0 (1 unit hydrolyzes 1.0 pmole ethyl butyrate per min¬
ute at pH 8.0, 23°) was diluted in buffer and 7.0 to 14.0
units were added to test substrates.
A 100,000g supernatant from a mouse liver homogenate
was used as a source of non-specific esterases (24).

Four

CD-I mice 8 to 10 weeks old were killed by cervical disloca¬
tion.

A 20% weight per volume homogenate of the livers was

prepared with a Potter-Elvehjem homogenizer in 0.25 M sucrose
(pH 7.5) and centrifuged at 100,000g for one hour at 3°.

The
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supernatant was added to the various reaction mixtures in
amounts equal to 5 and 20% of the total volume of the
reaction mixture.
The activity of the above enzymes on the following
substrates was tested*

succinylcholine chloride (Sigma),

propionylcholine chloride (Calbiochem), tri-fluoro-N-acetyl
methyl ester of aspartic acid (TFAMeAsp)

(kindly supplied

by Dr. Pauline Chang of the Department of Pharmacology)
and AcFAsnMe.
The liberation of acid was monitored as the ester was
cleaved according to the procedure of Augustinsson with a
Radiometer pH meter and titrator unit {25) •

Between 2.0

and 4,0 ml of solution containing 20 to 80 pinoles of sub¬
strate were placed in a small test tube in which the pH
electrode and titrant pipet were immersed.

The reaction

mixture was stirred magnetically and rapidly adjusted to
between pH 7*0 and 8.0 with a solution of NaCH (standardized
to 1.000 N).

Several minutes of titration were performed

in the absence of enzyme to assess non-enzymatic hydrolysis
of the substrate.

The enzyme was added and the rate of acid

liberation determined for at least 10 minutes.
In all calculations, the acid produced by spontaneous
liberation from substrate or enzyme alone was subtracted
from the acid liberated during the reaction in the presence
of substrate and enzyme.

The enzyme activity was expressed

in pmoles of substrate hydrolyzed per minute per unit enzyme.
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Hog kidney acylase (Sigma) with a deacylation activity
of 800 pmoles/hour/mg with N-acetyl-L-methionine as sub¬
strate was dissolved in 0.01 M potassium phosphate buffer,
pH 7.0.

The test substrates N-acetyl-L-asparagine (Sigma)

and AcFAsnMe were dissolved in the same buffer.
Initially, 1.0 ml N-acetyl-L-asparagine (1 mM) or
AcFAsnMe (2 mM) solution was incubated at 25° with 0.25 mg
acylase and samples were removed for analysis at 5# 10, and
15 minutes.

In the second set of experiments conducted at

37°* substrate concentrations were increased to 20 mM and
the amount of acylase increased to 2.5 or 5.0 mg per ml.
Acylase activity was monitored by a fluorometric assay
based on the reaction of the liberated o<-amino group with
o-phthalaldehyde to produce a fluorescent compound.

One

tenth ml portions of the reaction mixture were added to 3*0
ml of buffered reagent which was prepared fresh daily accord¬
ing to the method of Roth (26).

To 90 ml of 0.05 M borate

buffer, pH 8.0, 50 mg of o-phthalaldehyde (Durrum) in 1.0 ml

95% ethanol and 10 pi of 2-mercaptoethanol were added and
mixed.

Fluorescence was monitored with a Farrand MK-1 spec-

trofluorometer with the monochromators set at ^ex = 3^0 nm
and*^ = 455 nm and values were recorded in microamperes
after a one minute reaction time (27).

A standard curve was

prepared with L-asparagine in the range 2.5 to 16 pM (Figure 1).
For calculation, the amount of fluorescence obtained from the
presence of cC-amino groups in the enzyme alone and from any
non-enzymatic hydrolysis of substrate was subtracted from the

FLUORESCENCE (/xamperes).
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Figure 1.
Standard Curve for the Detection of
L-Asparagine (L-Asn) with o-Phthalaldehyde.
One-tenth ml L-Asn in distilled water (0.06 to
0.5 mM) was added to
ml buffered reagent
and fluorescence was recorded after 1 minute.
Details are given in the text.

14
fluorescence obtained during the reaction of acylase and
substrate.

Enzyme activity was expressed in pmoles of

substrate deacylated per minute per mg enzyme.
III.
Chemical Studies on the Formation of 2-(N-Acetvl)aminomaleimide (NAAMj.
Ultraviolet spectra were determined with a Cary 15
spectrophotometer.

Nuclear magnetic resonance spectra of

hydrogen were determined by Dr. Ann Jakubowski with a
Varian T-60 analytical NMR spectrometer at 60 MgHz.

Struc¬

tural groups were assigned on the basis of the charged inte¬
grals and the chemical shifts relative to the external stand¬
ard tetramethylsilane (TMS) = 0.00 ppm (28).

Fluorine reso¬

nance spectra were performed by Dr. Ian Armitage with a
Bruker HFX 90 NMR spectrometer modified for multinuclear
operation, in Fourier transformed mode at 84.6 MgHz for
•*-9fluorine.
Mass spectroscopy data was determined at Wesleyan
University through arrangements made by Dr. Ann Jakubowski,
and elemental analysis was performed by Baron Analytical
Services, Orange, Ct.
Thin-layer chromatography was performed on 20 x 20 cm
silica gel sheets (Baker Chemical Company).

The solvent

contained n-butanol, acetic acid and water in a 4:lil ratio,
respectively.
lamp.

Compounds were detected under an ultraviolet

In the case of AcFAsnMe it was necessary to heat the

plate to 100° for 3 to 5 minutes to visualize a UV absorb¬
ing spot.

RESULTS
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RESULTS
I.
Cell Culture Studies with D.L-Threo-N^-acetyl-3-fluoroasparagine Methyl Ester (AcFAsnMe) .
The cytotoxicity of AcFAsnMe against L5178Y cells is
shown in Figure 2.

At 2.4 x 10“^ M AcFAsnMe, nearly total

cell lysis was observed microscopically even though Coulter
counts indicated stasis of growth, whereas at the lower con¬
centrations dose-dependent growth inhibition was seen.

L-As-

paragine was added in an attempt to prevent the growth inhibi¬
tion caused by AcFAsnMe; although a minimal protective effect
was observed, this concentration of L-asparagine also caused
a slight increase in the growth rate of controls (Figure 3)«
Since it had been shown that AcFAsnMe was unstable in
culture, these same concentrations of drug were pre-incubated
for 20 hours in the absence of cells (Figure 4).

The decompo¬

sition products formed under these conditions also caused a
similar degree of growth inhibition.
Additional cell culture studies were done to determine
whether the minimal protective effect seen by L-asparagine
during incubation of L51?8Y cells with AcFAsnMe could be re¬
produced by substitution of another amino acid.

L-Glutamine

was found to provide an equivalent protective effect (Figure 5)»
Thus, the specificity of AcFAsnMe as an asparagine analog might
be questioned.

17

5

TIME (hours)
Figure 2.
The Growth Inhibition of L5178Y
Cells by AcFAsnMe.
0——e = Control
A--A = 6*1 x 10 "-5 M AcFAsnlvIe
□-—a = 1.2 x 10~f M AcFAsnMe
o——o = 2.4 x 10
M AcFAsnMe
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Figure 3.
The Effects of AcFAsnMe and L-Asparagine
(L-Asn) on Growth of L51?8Y Cells.
to-® = Control
O-O = Control with 8.0 x 10“3 M L-Asn
&
a = 6.1 x 10“5 M AcFAsnMe
&
A = 6.1 x 10”3 jvi AcFAsnlvie with 8.0 x 10”3 M L-Asn
0-- 2.4 x 10M AcFAsnMe
P-□ = 2.4 x 10
M AcFAsnlvie with 8.0 x 10~3 m L-Asn

CELLS/ML
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0

24

48
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TIME (hours)
Figure 4,
The Effects of AcFAsnMe and L-Asparagine (L-Asn) on Growth of L5178Y Cells* AcFAsnMe
was pre-incubated for 20 hours in media with or
without L-Asn prior to addition of cells*
©-© = Control
O-0 = Control with 8.0 x 10“3 M L-Asn
L-A = 6.1 x 10"5 M AcFAsnMe
Cx-A = 6*1 x 10"3 ivi AcFAsnMe with 8*0 x 10”3 m L-Asn
B--e = 2.4 x 10“^ M AcFAsnMe
□-o = 2.4 x 10“^ M AcFAsnMe with 8.0 x 10"3 M L-Asn
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1

0

1

24

1

J

48

72

TIME (hours)
Figure 5*
The Effects of AcFAsnMe and L-Glutamine
(L-Gln) on Growth of L5178Y Cells*
©-© = Control
0-0 = Control with 5*2 x 10~3 M L-Gln
A-A = 6.1 x 10”3 M AcFAsnMe
A-&= 6.1 x 10 y M AcFAsnMe with 5*2 x 10“3 m L-Gln
»-0= 1.2 x 10"7 M AcFAsnMe
O-0= 1.2 x 10"4 M AcFAsnMe with 5.2 x 10~3 m L-Gln
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II.

Enzymatic Treatment of AcFAsnMe.
An attempt was made to remove enzymatically the block¬

ing groups from AcFAsnMe to liberate free 3**fluoroasparagine
which was initially proposed as the compound responsible for
inhibition.

Table I gives the hydrolysis rates for the var¬

ious test substrates by the enzymes.

Although succinylcholine

and propionylcholine chloride acted as substrates for esterase
type I and pseudocholinesterase, respectively, the tri-fluoroN-acetyl methyl ester of L-aspartic acid (TFAMeAsp), a com¬
pound similar in structure to AcFAsnMe, and AcFAsnMe itself
were not hydrolyzed to any significant degree by either of
these enzymes.

However, a 20 per cent by volume supernatant

(100,000g) from mouse liver homogenate containing non-specific
esterases was found to hydrolyze both TFAMeAsp and AcFAsnMe
as evidenced by liberation of acid at a low but significant
rate (Table 2).
AcFAsnMe was also incubated with hog kidney acylase I
in an attempt to remove the acyl group.

The amount of <*-amino

group liberated during incubation of substrate and enzyme
after correction for non-enzymatic hydrolysis of substrate
and c<-amino groups present in the enzyme itself was within the
linear range of the standard curve (see Figure 1, Materials
and Methods).

N-Acetyl-L-asparagine was deacylated at a rate

of 0.7^ pmoles per minute per mg enzyme at 25°, but there was
no evidence of deacylation of AcFAsnMe.

Even at 37° with a

10-fold increase in substrate and enzyme concentrations, the
observed rate of AcFAsnMe deacylated was less than 0.20 pinoles
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TABLE I

Substrate

Hydrolysis Rate
(pmoles hydrolyzed/
m in/unit enzyme, 25°)

Enzyme

Succinylcholine
chloride

Esterase, Type I

0.20

Succinylcholine
chloride

Esterase, Type II

0.044

Propionylcholine
chloride

Pseudocholinesterase

0.20

TFAMeAsp

Pseudocholinesterase

<0.004

TFAMeAsp

Esterase, Type I

<0.015

TFAMeAsp

Esterase, Type II

<0.010

AcFAsnMe

Pseudocholinesterase

<0.004

AcFAsnMe

Esterase, Type I

<0.006

AcFAsnMe

Esterase, Type II

<0.005

Table I.
The Hydrolysis of AcFAsnMe and Other Substrates by
Various Esterases.
All substrates were present at a concen¬
tration of 10 mM.
Control rates indicating non-enzymatic
hydrolysis of substrate were 0 001
Details of the exper¬
imental technique as well as the exact units of enzyme added
to start the reaction are given in Materials and Methods.

< .

.
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TABLE II

Substrate

Supernatant
($ volume)

Hydrolysis Rate
(pnoles hydrolyzed/
minute, 25°)

Propionylcholine
chloride

5

<0.01

Propionylcholine
chloride

20

0.04

TFAMeAsp

5

0.07

TFAMeAsp

20

0.30

AcFAsnMe

5

<0.02

AcFAsnMe

20

0.13

Table II.
The Hydrolysis of AcFAsnMe and Other Substrates
by Supernatant (100,000g) from Mouse Liver Homogenate. All
substrates were present at a concentration of 20 ml'.i.
There
was no apparent liberation of acid from enzyme alone and
control rates for substrate alone were 0.002.
Details of
the experimental technique are given in Materials and Methods.
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per minute per mg enzyme.

Further studies v/ould be needed

to determine whether AcFAsnMe is indeed hydrolyzed by this
acylase to a significant degree.
III.
Chemical Studies on the Formation of 2-(N-Acetvl)aminomaleimide (NAAM).
Duschinsky reported that incubation of AcFAsnMe in
culture media gave rise to an increased absorbance at 233 nm.
Since essentially equal inhibition of L5178Y cell growth was
observed after 20 hour pre-incubation, investigation of the
chemical nature of the 233 nm absorbing product was undertaken.
A solution of AcFAsnMe (2.5 ml, 1 x 10“^ M) in distilled water
was rapidly titrated to an endpoint of pH 8.8 with a Radio¬
meter pH meter and titrator.

The subsequent liberation of

acid was monitored at pH 8.8 by the addition of 1.000 N NaOH
until the reaction was complete (Figure 6).

One mole of acid

was liberated for every mole of AcFAsnMe present.

The initial

rate of acid production at pH 8.8 was 0.7 pmoles per minute.
To monitor the change in UV absorbance during this base-cat¬
alyzed reaction, AcFAsnMe (10“^ M) was prepared in 0.05 M
borate buffer pH 8.8 and scanned at 10 minute intervals be¬
tween 210 and

300

nm in the UV spectrophotometer to monitor

the formation of the 233 nm absorbing product as well as other
changes in UV absorbance (Figure 7)«

It should be noted that

the presence of buffer ion may effect the reaction of AcFAsnMe
at pH 8.8 and therefore the reaction of this compound in dis¬
tilled water may be different from that in buffer.

At any

NaOH CONSUMED (/xmoles)
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Figure 6.
The Liberation of Acid from AcFAsnMe at
pH 8.8. AcFAsnMe was present at an initial concen
tration of 0.01 M with 25 pmoles available for
reaction.
Details of the experimental technique
are given in the text.
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Figure 7* Ultraviolet Spectra During the Liberation
of Acid from AcFAsnMe at pH 8.8. AcFAsnMe was present
at a concentration of 10” M in 0*05 M borate buffer
pH 8.8.
The number on each spectrum indicates the
reaction time in minutes.
Details are given in the
text.
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rate, it appears from Figure 7 that the formation of 233 nm
absorbing product is preceded by that of a substance which
absorbs at lower wavelengths.

Along with the formation of a

peak at 233 ran, the spectra slso indicate the simultaneous
formation of at least two other products.

Certainly, it is

apparent that the reaction of AcFAsnMe at pH 8.8 is not a
simple one.

The liberation of acid from AcFAsnMe was also

monitored at pH 10.0 by the previously described method.
This resulted in a more than 5-fold increase in the rate of
acid production.

However, the increase from pH 8.8 to pH

10.0 also resulted in a greater than 10-fold increase in the
rate of formation of absorbance at 267 nm (calculated from
G = 8800 which is based on the original concentration of
AcFAsnMe) and therefore subsequent titrations were performed
at the lower pH to optimize the formation of the 233 nm product.
When the starting concentration of AcFAsnMe was increased
to 0.25 M (50 mg in 1.0 ml water), the conversion to 233 nm
absorbing product was accompanied first by a color change of
the solution from clear to faint yellow.

Within minutes a

crystalline precipitate formed which was filtered under suc¬
tion to yield 20.5 mg; recrystallization from water gave 14.5
mg.

The ultraviolet spectrum of the recrystallized product

in water showed a UV maximum at 233 ran (G = 17,800) with a
broad peak in the range 315-330 nm (Figure 8).
very little absorbance in the 267 nm range.

There was

The NMR spectrum

of the recrystallized product in deuterated dimethyl sulfox¬
ide (DMS0) gave the following chemical shifts relative to the
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WAVELENGTH (nm)
Figure 8* Ultraviolet Spectrum of Recrystallized NAAMo
The compound was present at a concentration of 5.0 x 10"5 Ivl
in distilled water.
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external standard tetramethylsilane (TMS)i
singlet), 6.1 ppm (1H, singlet).

2.0 ppm (3H,

This is to be compared

with the NMR spectrum of AcFAsnMe in deuterated water
(D£0) with the same standardi

2.2 ppm (3H, singlet),

3*9 ppm (3H, singlet), 5»3 ppm (1H, doublet of doublets,
*^CHCHF 82 3^ Hz, *^CHCH *“ ^ 2 Hz), 3*7 ppm (1H, doublet of
doublets, JpQH ~ ^6 Hz, JCHCH = <2 Hz).

It was thus evi-

dent that formation of 233 nm absorbing product from AcFAsnMe
had resulted in liberation of MeOH as well as HF.

This was

in agreement with the fluorine magnetic resonance studies
which showed the chemical shift of the fluorine present in
AcFAsnMe in D£0 to be 122 ppm upfield relative to the exter¬
nal standard tri-fluoroacetate.

This peak was not present

in a spectrum of the recrystallized 233 ran absorbing product,
again suggesting that fluorine had been liberated during the
reaction of AcFAsnMe at pH 8.8.

A fluorine resonance spec¬

trum did reveal the presence of fluoride ion in the filtrate
after removal of the 233 nm absorbing material.
From the above data, the proposed structure for the 233
nm absorbing compound is 2-(N-acetyl)-aminomaleimide (NAAM):
H

HO

H
It is a white crystalline solid which is stable for months
when dessicated at 3°*

It is sparingly soluble in cold
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water and very soluble in DMSO.

With slow heating it

decomposes at 260° and with rapid heating there is evi¬
dence of sublimation.

Mass spectroscopy showed the parent

ion to be at m/e 15** with a molecular (parent)
155*

ion at m/e

Thus, the molecular weight of NAAM was determined to

be 15** (29)*

Elemental analysis yielded 46.91% C, 3*83% H,

18.21% N (theoretical - 46.75% C, 3.93% H, 18.18% N).
Thin-layer chromatography with n-BuOHtAcOHi^O (4ilil)
as solvent revealed NAAM to be a strongly fluorescent com¬
pound (Rf = 0.66), whereas AcFAsnMe in the same solvent was
detected under UV light only after heating at 100° for sev¬
eral minutes (R^ = 0.52) as described by Duschinsky.
Investigation of the UV absorbing materials present in
the aqueous filtrate after removal of NAAM (Figure 9) was
then undertaken.

The filtrate contained considerable mater¬

ial that absorbed in the region of 265 rim.

To determine

whether this product had formed from NAAM, a 3*8 x 10

M

aqueous solution of NAAM was adjusted to pH 9*6 and the con¬
sumption of base monitored at this pH with the Radiometer pH
meter and titrator for 60 minutes.

At this time, the pH was

inadvertently readjusted to pH 10.0, which explains the in¬
crease in rate observed at this point (Figure 10)•

The

reaction was complete after 110 minutes at which time nearly
one mole of acid had been liberated (30 pmoles) for every
mole of NAAM (36 pmoles)•

At completion of the reaction, an

ultraviolet spectrum showed the formation of a single peak
(Figure 11)

(£ = 10,400, based on the original concentration
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Figure 9. Ultraviolet Spectrum of Filtrate After Removal
of NAAM.
The initial concentration of AcFAsnMe was O.36 M.
The reaction occurred at pH 8.8 until complete, at which
time NAAM was removed by filtration.
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Figure 10.
Consumption
10.0* NAAM was present
36 mM (36 jumoles in 1.0
readjusted to pH 10.0.

of Base by NAAM at pH 9.6 and
at an initial concentration of
ml). At 60 minutes, the pH was
Details are given in the text.
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WAVELENGTH (nm)
Figure 11. Ultraviolet Spectrum of Material Formed from
NAAM at pH 10.00
The initial concentration of NAAM was
36 mM.
The above spectrum represents 3 pi of the completed
reaction mixture in 2.5 ml distilled water.
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of NAAM) which suggests that formation of a product with an
absorption maximum in the region of 265 nm proceeds through
formation of NAAM.

The product was readjusted to neutral

pH and submitted to thin-layer chromatography with the sol¬
vent n-BuOHiAcCH:H2O (4*ltl).

The compound was UV absorbing,

non-fluorescent, and had an R^ value of 0.57*
In an attempt to characterize further this 265 nm ab¬
sorbing product, a solution of NAAM that had been converted
to 265 nm absorbing material at pH 10.0 as described above
was re-titrated from pH 10.0 to pH 3»1 with 0.1 N HC1 (Figure
12).

Although the 265 nm absorbing material had no ionizing

groups in the pH range 10 to 4, an acid ionization may exist
with a pKa below 3*5*
In addition to the 265 nm absorbing material, the UV
spectrum of the filtrate after removal of NAAM (Figure 9)
showed the presence of another material absorbing in the
240 to 250 nm range.

This was verified by thin-layer chrom¬

atography of the filtrate (readjusted to neutral pH)

in the

previously described solvent system which yielded four pro¬
ducts (Figure 13)•

One was strongly fluorescent (R^ = 0.66)

and could be attributed to the small amount of NAAM soluble
in the aqueous filtrate.

One product (R^ = 0.53) was only

faintly visible after heating, probably representing a small
amount of unreacted AcFAsnMe.

The other two products (R^ =

0.34 and 0.62) appeared as dark spots under the UV lamp.

The

substance with an R^ value of 0.62 may represent the 265 nm
absorbing material formed from NAAM (Rf = 0.57)

(Figure 13).

^(.equivalents H+ ADDED
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Figure 12.
The Titration of 265 nm Absorbing Product
from pH 10,0 to pH 3*0*
Twenty-eight jumoies (23 mM,
1*2 ml) of NAAM were converted to 265 nm absorbing
product at pH 10*0*
Titrant = 0*1 N KC1*

36

SOLVENT FRCNT

0

r\

8

^

©

•

NAAM

0
©

o

o

♦

«

•

Filtrate
AcFAsnMe
NAAM
Filtrate
to pH 10*0
to pH 10*0

Figure 13*
Thin-layer Chromatography of AcFAsnMe,
NAAM, and Additional Degradation Products*
The
solvent contained n-BuOH*AcOH*H20 (4ilil). ®
indicates compounds which appeared strongly fluo¬
rescent* ® indicates compounds which appeared
only after heating* All other compounds appeared
as dark spots under the UV lamp*
Further details
are given in the text*
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Apparently the product with an Rf value of 0.34 is the com¬
pound which absorbs in the 240 to 250 nm range*

As an addi¬

tional study, the filtrate from reaction at pH 8.8 was adjust
ed to pH 10.0 and allowed to react until the liberation of
acid ceased.

A UV spectrum of the reacted filtrate showed

the presence of the 265 nm absorbing material along with the
questionable presence of another material absorbing in the
240 to 250 nm range (Figure 14).

Thin-layer chromatography

of the reacted filtrate in the above solvent revealed the
presence of two UV absorbing, non-fluorescent compounds
with Rf values of 0.34 and 0.62 (Figure 13)•

These values

are identical to the Rj> values of the two substances (other
than NAAM and AcFAsnMe) present in the unreacted filtrate.
This suggests that the product that absorbs in the 240 to
250 nm range is not converted to the 265 nm absorbing pro¬
duct.

Since it was subsequently shown that the latter two

products present in the filtrate did not inhibit leukemic
cells in culture, further characterization of these compounds
was not undertaken.
IV.

Cytotoxicity of the Products of AcFAsnMe Degradation.
An aqueous solution of recrystallized NAAM was tested

in cell culture at concentrations between 2.0 x 10“^ M and
1.6 x 10“^ M using the same methods previously described
(Figure 15)*

It can be seen that NAAM caused an essentially

identical pattern of growth inhibition when compared to
AcFAsnMe.

To determine if the material formed by treatment

of AcFAsnMe with strong base was also cytotoxic, an aqueous
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Figure 14.
Ultraviolet Spectrum of Material Formed from the
Filtrate.
The initial concentration of AcFAsnMe was O.36 M.
The filtrate was adjusted to pH 10.0 and allowed to react
until the liberation of acid ceased.
The above spectrum
represents 3 pi of this reaction mixture in 2.5 ml of dis¬
tilled water.
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Figure 15*
NAAM •

The Growth Inhibition of L5178Y by

O-Q
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□-□
A-A
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2.0 x 10”5
4.0 x 10**^
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solution of AcFAsnMe was titrated to pH 12 and allowed to
react until the liberation of acid ceased.

The resulting

UV spectrum was identical to that seen in Figure 14.

The

solution was readjusted to neutral pH, sterile filtered,
and tested in cell culture by the methods previously de¬
scribed at concentrations between 6.1 x 10“5 m and 4.8 x
10M based on the original concentration of AcFAsnMe.
It was evident that this material was not contributing to
inhibition of cell growth (Figure 16).

In addition, a 100-

fold dilution of the filtrate after removal of NAAM, which
would be the equivalent of 1.1 x 10“^ M AcFAsnMe, was also
tested in cell culture and found to be inactive (Figure 17).
Thus, any other reaction products from AcFAsnMe formed in the
culture (or at pH 8.8) were essentially inactive as inhibi¬
tors of the growth of the lymphoblasts.
To determine whether the fluoride ion liberated from
AcFAsnMe in the form of HF during incubation had any effect
on cell growth, NaF at concentrations between 2.4 x 10“^ and
6.1 x 10“5 m was tested in cell culture (Figure 18).

No

significant inhibition of cell growth was seen which is in
agreement with the data of Duschinsky (22).
It is therefore concluded that the growth inhibition of
L51?8Y by AcFAsnMe can be attributed to formation of the
acetyl-aminomaleimide structure.

CELLS/ML
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Figure 16.
The Effect of Material Formed from
Reaction of AcFAsnMe at pH 12.0.
The concen¬
trations below are based on the initial concen¬
tration of AcFAsnMe (4.3 x 10“^ M).
®—:—© = Control
O-0 = 6.1 x 10“5 M (AcFAsnMe)
x-X = 1.2 x 10“7 M (AcFAsnlvle)
4-A = 2.4 x 10“7 M (AcFAsnMe)
D-a = 4.8 x 10M (AcFAsnMe)

CELLS/ML

42

Figure 1?.
The Effect of Filtrate on the Growth of
L5178Y Cells.
The initial concentration of AcFAsnMe
was 0.15 M. After completion of the reaction at pH
8.8, NAAM was removed by filtration.
Further de¬
tails of the experimental technique are given in the
text.
The concentrations below are based on the
initial concentration of AcFAsnMe.
0-0 = Control
0-0 = 5*0 x 10 "y M (AcFAsnMe)
0-0 = 1.1 x 10“4 M (AcFAsnMe)

CELLS/ML
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Figure 18.
The Effect of NaF on
L5178Y Cells.
•-• *= Control
o-o = 6.1 X 107 M
0-a = 1.2 x 10"7 M
A--A = 2.4 x 10”4 M

the Growth of
NaF
NaF
NaF

DISCUSSION

45

DISCUSSION

The initial studies with cell culture in this thesis
resulted in the introduction of 24-well Linbro plates for
testing the cytotoxicity of drugs.

This system makes pos¬

sible the growth of cells in only 1 ml of media which is
particularly useful when only small quantities of drug are
available.

In addition, several conditions can be included

on one plate affording simple and rapid set up of assays and
harvesting for the determination of cell counts.

Contamina¬

tion never occurred during the ?2 hour assays and L51?8Y
cells grew at doubling rates as low as 9 to 10 hours which
are as good if not better than those found using standard
cell culture tubes with 5 ml of medium (30).
The intended theme of this research was that D,L-threoN^-acetyl-3-fluoroasparagine methyl ester (AcFAsnMe) might
function as an analog of asparagine.

Although this compound

was shown to be cytotoxic for cell cultures at concentrations
reported by Duschinsky, the proposed mechanism of action must
now be questioned.

Metabolic liberation of free 3-fluoro-

asparagine was expected to either limit the availability of
L-asparagine to the cell, be incorporated in its place, or
feedback inhibit asparagine biosynthesis.

Such a mechanism

might have been hoped to expand the spectrum of L-asparaginase therapy.

This mode of action became less likely since

addition of large amounts of asparagine to cell cultures could
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only minimally prevent the cytotoxic effects of AcFAsnMe.
Furthermore, glutamine was approximately equal in its effect,
suggesting that this was not an asparagine specific effect.
In fact, control cultures supplemented with excesses of
these amino acids grew slightly better.

This could account

for the apparent increase in growth seen when these amino
acid supplements were added to cultures containing AcFAsnMe•
In addition. Dr. David Cooney at the National Institutes of
Health tested AcFAsnMe as a possible inhibitor of asparagine
synthetase.

At a final concentration of 1 mM, no inhibition

of crude asparagine synthetase derived from tumor or pan¬
creatic tissue was seen (31)•

These experiments of course

did not exclude potential activity of the unblocked analog.
Finally, as shown below, the equal activity of 2-(N-acetyl)aminomaleimide (NAAM) as a cytotoxic agent would suggest that
all cytotoxic activity of AcFAsnMe is actually a consequence
of the chemical degradation product formed in tissue culture
medium in the absence of leukemic cells.
Prior to this finding, however, a number of attempts
were made to de-block AcFAsnMe with esterases.

These were un¬

successful probably because of steric hindrance by the N-acetyl
group which blocked entry of AcFAsnMe into the active site.
The inability of the tri-fluoro-N-acetyl methyl ester to act
as a substrate supports this idea.

The activity of pseudo¬

cholinesterase, in particular, declines rapidly as substrates
lose their structural resemblance to butyrylcholine (32),
and chain branching in the carbon atom next to the ester link

47
has a particularly adverse effect on the rate of hydrolysis
(33)•

Pseudocholinesterase is known to hydrolyze non-cho-

line esters, but a structural resemblance to butyrate is
preferable (34).

On the other hand, the purified carboxyl-

esterases tested in these experiments could have been expect¬
ed to hydrolyze AcFAsnMe at a significant rate, as these
enzymes possess a wide range of specificity (35)*

Carboxyl-

esterases in general are widely distributed in vertebrate
tissues and blood serum, with the highest activities in mam¬
mals being in the liver, kidneys, duodenum and brain (35)*
However, even when a 20% by volume supernatant (100,Q00g) from
mouse liver homogenate was added to AcFAsnMe, a relatively
low rate of hydrolysis resulted.

For this reason, along

with increasing evidence that AcFAsnMe was not acting as an
asparagine analog, further studies such as purification of
the esterases present in the homogenate were not undertaken.
Similarly, several attempts at deacylation of AcFAsnMe
by hog kidney acylase were also unsuccessful.

In this case,

however, purified acylases other than that from hog kidney
were not available for testing.

Here, also, increasing evi¬

dence that AcFAsnMe itself was not the compound responsible
for inhibition did not encourage further attempts at deacyla¬
tion.
Therefore, the main focus of this thesis turned from
AcFAsnMe to the characterization of the degradation products
formed during incubation of AcFAsnMe in media at 3?°»

At

least one of these products was responsible for inhibition

48
of L5178Y cells based on the results of the pre-incubation
studies.

It was indeed fortunate that during the reaction

of relatively high concentrations of AcFAsnMe at pH 8.8,
one of the products was only sparingly soluble in water
and therefore precipitated.

Thus, further characterization

of this product was possible.
Proton and fluorine magnetic resonance spectra, mass
spectroscopy studies, and elemental analysis were all con¬
sistent with the loss of HF and MeOH to form NAAM.

An ultra¬

violet spectrum verified that this was the material respon¬
sible for absorption at 233 ran.

It might be noted that show-

domycin, a nucleoside antibiotic with a maleimide structure,
has an ultraviolet maximum at 220 nm (36).

The property of

fluorescence which an aqueous solution of NAAM possesses is
also consistent with the known fluorescence of certain
maleimide derivatives (37)*

The results from the titration

of NAAM also reflect its maleimide structure.

During rapid

titration of NAM from pH 6.5 to pH 9.5 prior to formation of
265 nm absorbing material, less than 2 pmoles of base were
required with 36 pmoles of NAAM available for titration.
This strongly suggests that there are no ionizing groups in
this pH range.

Similarly, during titration of NAM from

pH 5»5 with acid, there were no titratable groups at least
down to pH 3*

The pKa of the imide proton in maleimide is

9.5 (36), but it appears that the pKa of the imide proton in
NAM is above 9*5•
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Crystalline NAM caused an essentially equal degree of
growth inhibition when compared to AcFAsnMe•

This is in

agreement with the studies involving pre-incubation of
AcFAsnMe in media prior to addition of cells.

Since the

other degradation products formed during incubation of
AcFAsnMe were shown to be inactive in cell culture, NAM
was concluded to be the compound responsible for inhibition
of L5178Y cells.

Presumably, this previously unreported

compound acts as an alkylating agent as numerous other maleimide derivatives have been shown to function.

N-Ethyl-

male imide is known to react rapidly and specifically with
sulfhydryl groups (38,39)*

Showdomycin selectively inhibits

certain enzymes, probably due to the alkylating property of
its maleimide structure (40).

More specifically, maleimide

itself has recently been shown to be a potent and irrevers¬
ible inhibitor of the L-asparagine synthetase from L51?8Y
asparagine-independent mouse leukemia (41).

L-Asparagine

did not reduce the lethal effects of maleimide in vivo, thus
eliminating the possibility of its acting as a substrate
analog.

It was concluded from this study that maleimide

inhibited the enzymes of L-asparagine metabolism due to its
ability to form covalent bonds with critical sulfhydryl com¬
pounds (41).

In this regard, some initial studies with NAAM

indicated that it did react with L-cysteine, a strong nucleo¬
phile.

Further studies in this area would be needed to con¬

firm the action of NAAM as an alkylating agent.

These could

include reaction of NAAM with other strong nucleophiles such
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as glutathione, which is known to react with maleimides
(38)#

Alternatively, glutathione could he incubated with

NAAM under culture conditions to determine whether the de¬
gree of growth inhibition could be nullified, presumably
by binding of glutathione to NAAM to inactivate the latter.
In fact, maleimides are known to react with amino acids (39)
and perhaps this could explain, at least in part, why addi¬
tional quantities of asparagine or glutamine in cultures
with NAAM showed an increase in growth rate when compared
with cultures that did not contain the amino acid.

In addi¬

tion, however, the increased growth rate in control cultures
must be acknowledged to be responsible for the apparent reduc
tion in inhibition.
The results from incubation of NAAM with L5178Y cells
also indicate that the inhibition of growth is time-dependent
with the degree of inhibition becoming greater after 24 hours
of incubation (see Figure 15, Results).

A similar effect

was seen with maleimide which was unable to inhibit L-asparagine synthetase in vivo soon after injection (41).

The time

course of the inhibition by NAAM suggests that the compound
is inhibiting protein synthesis.

This possibility could be

further investigated with in vivo studies to determine the
effect of administration of NAAM on the incorporation of a
radioactively labeled amino acid into the protein of L5178Y
cells.

Alternatively, NAAM may have to be metabolized before

it can act as an inhibitor of certain enzymes, which could
be determined by following the fate of radioactively labeled
NAAM.
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Although the biological properties of NAAM described
above were important aspects of this thesis, the chemistry
of the formation of this compound as well as the other pro¬
ducts formed during incubation of AcFAsnMe was a main focus.
From the results of these chemical studies, the formation of
NAAM under physiologic conditions and at pH 8.8 was proposed
to occur according to the mechanism shown in Figure 19*

Al¬

though detailed kinetic studies were not performed during
the course of these experiments, it did appear that there
was a five-fold increase in the rate of acid liberation when
the pH was increased from 8.8 to 10.0.

This suggests that

the initial reaction is a general base-catalyzed reaction.
The reaction of base with AcFAsnMe might be expected to in¬
volve ^-proton abstraction with formation of a carbanion as
depicted in Figure 19*

This would readily lead to /-elimin¬

ation of the fluorine atom (42).

An analogous situation is

the interaction of base on the surface of enzyme bound to
pyridoxal phosphate with compounds such as /-fluoro-D-Lalanine to effect elimination of HF (43).

The formation of

the carbanion is necessary to explain the lack of a quanti¬
tative conversion of AcFAsnMe to NAAM.

Although AcFAsnMe is

in the threo- configuration, if it were to liberate HF through
this planar intermediate, both cis- and trans- isomeric pro¬
ducts would result.

Presumably, the trans- isomer was then

free to ring close with loss of MeCH to form a maleimide which
precipitated due to its relative insolubility in water.

This

trans- isomer may be the material with UV absorption in the
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FIGURE 19

THE PROPOSED REACTION SCHEME FOR AcFAsnMe
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220 run range which precedes formation of the 233 nm material
(see Figure 7* Results).

It is assumed that the other isomer

was water soluble and remained in the filtrate.

This was

confirmed by ultraviolet spectroscopy and thin-layer chrom¬
atography.

It appears that this cis- isomer is the material

responsible for absorption in the 240 to 250 nm range.

Re¬

sults also indicated that this compound was not converted to
the 265 nm absorbing product upon base addition to the fil¬
trate and that it remained unchanged.

If one assumes that

one-half of the starting material was converted to each of
the isomers, as it appears from the quantititive yield of
NAAM from AcFAsnMe, the cis- isomer was found to be inac¬
tive against L5178Y cells at a calculated concentration of
5 x 1CT-5 M.
According to the mechanism depicted in Figure 19> the
liberation of acid from AcFAsnMe in the form HF would be ex¬
pected to correspond to formation of both the cis- and trans¬
isomers rather than to formation of NAAM with liberation of
MeOH.

This was tested by plotting the increase in absorbance

at both 220 nm (putative trans- isomer) and 233 nm (NAAM)
during the previously described reaction of AcFAsnMe (10“^ M)
in 0.05 M borate buffer pH 8.8.

These curves were then com¬

pared to the liberation of acid during reaction of AcFAsnMe
(0.01 M)

in distilled water (Figure 20).

The shape of the

latter curve appears to correspond more to the shape of the
curve showing change in absorbance at 220 nm, which suggests
that the liberation of acid does correlate with the formation
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Figure 20.
The Correlation of the Liberation of Acid with the
Increase in Absorbance at 220 nm During the Reaction of AcFAsnMe
at pH 8.8.
Details are given in the text.
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of the trans- compound.

However, more detailed kinetic

studies would be needed to confirm this.
The structure of the 265 nm absorbing product is less
certain.

Possibilities include removal of the N-acetyl

amide proton by base with formation of an azlactone deriv¬
ative (Figure 19)•

The high degree of unsaturation and the

existence of other resonance structures for this compound
might explain its ability to absorb at higher wavelengths.
However, azlactones are routinely prepared by the reaction
of o<-acylamido acids with sodium acetate and acetic anhy¬
dride at 100° (44), a rather severe set of conditions,
whereas the formation of the 265 nm absorbing product occurs
to some degree at pH 8.8, 25°*

Another more likely possibil¬

ity for formation of the 265 nm absorbing product is that
base addition results in removal of the -NH proton of the
maleimide ring which is then followed by base hydrolysis to
give ring opening.

As examples, both maleimide and shov/do-

mycin have been shown to undergo such a reaction upon expo¬
sure to base.

In fact, the UV maximum obtained in water for

these compounds (~275 nm) shifts to higher wavelengths
(~325 nm) upon exposure to base, which may be analogous to
the shift from 233 to 265 nm upon base addition to NAAM.

The

formation of this 265 nm absorbing material could explain the
addition of approximately one mole of base for each mole of
NAAM present, being equivalent to titration of the -NH proton.
This new compound would also be expected to contain an ion¬
izing group, presumably a carboxyl group, in the pH 3 range.
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as was suggested during titration of the compound.

However,

ring opening would also make an -NH2 group available for
titration and this was not apparent.

Clearly, further char¬

acterization of this compound would be necessary in order to
determine its actual structure.
In summary, this thesis investigated D.L-threo-N^acetyl-3-fluoroasparagine methyl ester (AcFAsnMe) as a cyto¬
toxic agent against L5178Y leukemic cells.

It was found that

this drug did not act as an asparagine analog as was initial¬
ly assumed, but rather through formation of 2-(N-acetyl)aminomaleimide (NAAM), which presumably acts as an alkyla¬
ting agent.

This product, a previously unreported chemical

entity, was characterized and a mechanism for its formation
proposed.

In addition, the biological and chemical proper¬

ties of the other degradation products formed on incubation
of AcFAsnMe in media were studied.

Finally, the question

might be raised as to whether NAAM would have any potential
application in the field of cancer chemotherapy.

More spec¬

ifically, could NAAM offer any advantages over other alkyla¬
ting agents such as maleimide?

In this regard, it has been

shown that L-asparagine synthetase exhibits distinctive sus¬
ceptibility to maleimide (41) and therefore this maleimide
derivative may still be considered for use in enhancing the
oncolytic effect of L-asparaginase.

Further studies on the

in vivo cytotoxicity of NAAM in animal models including the
possible toxic side effects are needed in order to answer
these questions.
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